ReviewOncoTargets and therapy2020

Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data.

Guillaume Beziat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.